06978 永泰生物-B
公司資料 - 股權變動
日期 股東名稱 披露原因 買入/賣出涉及
的股份數目
每股平均價 持有權益的
股份數目
佔已發行
股本(%)
27/03/2025Tianjin Dizhi Investment Management Co., Ltd.*(天津帝智投资管理有限公司)1711(L)0(L)0.00
27/03/2025Tianjin Shunqi Technology Development Partnership (Limited Partnership)*(天津顺祺科技发展合伙企业(有限合伙))1711(L)0(L)0.00
27/03/2025Tianjin Hongxun Technology Development Partnership (Limited Partnership)*(天津鸿勋科技发展合伙企业(有限合伙))1711(L)0(L)0.00
27/03/2025Tianjin Shanzhen Technology Development Partnership (Limited Partnership)*(天津善臻科技发展合伙企业(有限合伙))1711(L)0(L)0.00
27/03/2025Tianjin Tongming Technology Development Partnership (Limited Partnership)*(天津通明科技发展合伙企业(有限合伙))1711(L)0(L)0.00
27/03/2025吴迺峰1213(L)0(L)0.00
27/03/2025闫凯境1213(L)0(L)0.00
27/03/2025李畇慧1213(L)0(L)0.00
27/03/2025闫希军1213(L)0(L)0.00
27/03/2025Tasly Holding Group Co., Ltd.* (天士力控股集团有限公司)1711(L)0(L)0.00
27/03/2025Tianjin Fuhuade Technology Development Co., Ltd.*(天津富华德科技开发有限公司)1711(L)0(L)0.00
27/03/2025Tianjin Kangshun Technology Development Partnership (Limited Partnership)*(天津康顺科技发展合伙企业(有限合伙))1711(L)0(L)0.00
27/03/2025Tianjin Heyue Technology Development Partnership (Limited Partnership)*(天津和悦科技发展合伙企业(有限合伙))1711(L)0(L)0.00
27/03/2025Tianjin Tasly Health Industry Investment Group Co., Ltd.*(天津天士力大健康产业投资集团有限公司)1711(L)0(L)0.00
06/03/2025鄭鉉哲1213(L)-100,000(L)44,112,000(L)8.57
06/03/2025Evodevo Ltd1710(L)-100,000(L)44,112,000(L)8.57
05/03/2025Evodevo Ltd1710(L)-50,000(L)44,212,000(L)8.59
05/03/2025鄭鉉哲1213(L)-50,000(L)44,212,000(L)8.59
04/03/2025鄭鉉哲1213(L)-50,000(L)44,262,000(L)8.60
04/03/2025Evodevo Ltd1710(L)-50,000(L)44,262,000(L)8.60
03/03/2025鄭鉉哲1213(L)-47,000(L)44,312,000(L)8.61
03/03/2025Evodevo Ltd1710(L)-47,000(L)44,312,000(L)8.61
28/02/2025鄭鉉哲1213(L)-211,000(L)44,359,000(L)8.62
28/02/2025Evodevo Ltd1710(L)-211,000(L)44,359,000(L)8.62
27/02/2025Evodevo Ltd1710(L)-250,000(L)44,570,000(L)8.66
27/02/2025鄭鉉哲1213(L)-250,000(L)44,570,000(L)8.66
30/12/2024李畇慧1302(L)68,493,150(L)191,595,721(L)37.23
30/12/2024Tianjin Fuhuade Technology Development Co., Ltd. 天津富华德科技开发有限公司1302(L)68,493,150(L)191,595,721(L)37.23
30/12/2024江蘇濟川控股集團有限公司10031(L)+68,493,150(L)68,493,150(L)13.31
30/12/2024曹龍祥10031(L)+68,493,150(L)68,493,150(L)13.31
30/12/2024闫凯境1302(L)68,493,150(L)191,595,721(L)37.23
30/12/2024闫希军1302(L)68,493,150(L)191,595,721(L)37.23
30/12/2024曹飛10031(L)+68,493,150(L)68,493,150(L)13.31
30/12/2024西藏嘉澤創業投資有限公司10031(L)+68,493,150(L)68,493,150(L)13.31
30/12/2024Tasly (Hong Kong) Pharmaceutical Investment Limited1302(L)68,493,150(L)243,075,721(L)47.24
30/12/2024吴迺峰1302(L)68,493,150(L)191,595,721(L)37.23
04/08/2024China Resources Pharmaceutical Group Limited1711(L)+165,595,721(L)217,054,121(L)42.18
04/08/2024華潤三九醫藥股份有限公司China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.1711(L)+165,595,721(L)165,595,721(L)32.18
04/08/2024China Resources Company Limited1711(L)+165,595,721(L)217,054,121(L)42.18
 1  
備註: (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。
  (S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.